JEFFRY NURENBERG: Open Payments
NPI 1144396086 · NORTH PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 44 payments from 12 companies in 2025. Trend: 2023 $244 · 2024 $606 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $171 |
| Neurocrine BioSciences, Inc. | 5 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $93 |
| Teva Pharmaceuticals USA, Inc. | 5 | $86 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
| Alkermes, Inc. | 3 | $63 |
| Lundbeck LLC | 2 | $46 |
| Tris Pharma Inc | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, TRINTELLIX, AUSTEDO XR, REXULTI, COBENFY, ARISTADA.
Industry payments across FL — which companies pay providers there.
